Citations for
1CDK2, SEPTIN2
Coupling function of cyclin-dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma.
Xu C, Zhang W, Zhang X, Zhou D, Qu L, Liu J, Xiao M, Ni R, Jiang F, Ni W, Lu C.
Cancer Sci 110(2):540-549. doi: 10.1111/cas.13882. Epub 2018 Dec 26. 2019
2CDK2, EHMT1, NRF1
CDK2 regulates the NRF1/Ehmt1 axis during meiotic prophase I.
Palmer N, Talib SZA, Ratnacaram CK, Low D, Bisteau X, Lee JHS, Pfeiffenberger E, Wollmann H, Tan JHL, Wee S, Sobota R, Gunaratne J, Messerschmidt DM, Guccione E, Kaldis P.
J Cell Biol. Sep 2;218(9):2896-2918. doi: 10.1083/jcb.201903125. Epub 2019 Jul 26. 2019
3CCNE2, CCNK, CDK2
Cyclin K regulates prereplicative complex assembly to promote mammalian cell proliferation.
Lei T, Zhang P, Zhang X, Xiao X, Zhang J, Qiu T, Dai Q, Zhang Y, Min L, Li Q, Yin R, Ding P, Li N, Qu Y, Mu D, Qin J, Zhu X, Xiao ZX, Li Q.
Nat Commun 9(1):1876. doi: 10.1038/s41467-018-04258-w. 2018
4CCND1, CCNE1, CDK2, CDK4, CIAPIN1
The study on expression of CIAPIN1 interfering hepatocellular carcinoma cell proliferation and its mechanisms.
Huang Z, Su GF, Hu WJ, Bi XX, Zhang L, Wan G.
Eur Rev Med Pharmacol Sci 21(13):3054-3060. 2017
5CCNE1, CDK2, HOXA7
HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2.
Li Y, Yang XH, Fang SJ, Qin CF, Sun RL, Liu ZY, Jiang BY, Wu X, Li G.
Oncol Rep 33(2):990-6. doi: 10.3892/or.2014.3668. Epub 2014 Dec 11. 2015
6CDK2, KLF10, SIAH1
CDK2 phosphorylation regulates the protein stability of KLF10 by interfering with binding of the E3 ligase SIAH1.
Lin CH, Lin SY, Chang HW, Ko LJ, Tseng YS, Chang VH, Yu WC.
Biochim Biophys Acta 1853(5):1174-81. doi: 10.1016/j.bbamcr.2015.02.018. Epub 2015 Feb 26. 2015
7CCNA2, CDK2, PLA2G4A, SIRT2
Group IVA Cytosolic Phospholipase A2 Regulates the G2-to-M Transition by Modulating the Activity of Tumor Suppressor SIRT2.
Movahedi Naini S, Sheridan AM, Force T, Shah JV, Bonventre JV.
Mol Cell Biol 35(21):3768-84. doi: 10.1128/MCB.00184-15. Epub 2015 Aug 24. 2015
8CDK2, RNF4
CDK-mediated RNF4 phosphorylation regulates homologous recombination in S-phase.
Luo K, Deng M, Li Y, Wu C, Xu Z, Yuan J, Lou Z.
Nucleic Acids Res 43(11):5465-75. doi: 10.1093/nar/gkv434. Epub 2015 May 6. 2015
9CCP110, CDK2
CDK2 Inhibition Causes Anaphase Catastrophe in Lung Cancer through the Centrosomal Protein CP110.
Hu S, Danilov AV, Godek K, Orr B, Tafe LJ, Rodriguez-Canales J, Behrens C, Mino B, Moran CA, Memoli VA, Mustachio LM, Galimberti F, Ravi S, DeCastro A, Lu Y, Sekula D, Andrew AS, Wistuba II, Freemantle S, Compton DA, Dmitrovsky E.
Cancer Res 75(10):2029-38. doi: 10.1158/0008-5472.CAN-14-1494. Epub 2015 Mar 25. 2015
10CCNA2, CDK2, CIZ1
Cyclin-A-CDK2-mediated phosphorylation of CIZ1 blocks replisome formation and initiation of mammalian DNA replication.
Copeland NA, Sercombe HE, Wilson RH, Coverley D.
J Cell Sci 128(8):1518-27. doi: 10.1242/jcs.161919. Epub 2015 Mar 3. 2015
11CDK2, MYBBP1A, TPP2
TPPII, MYBBP1A and CDK2 form a protein-protein interaction network.
Nahálková J, Tomkinson B.
Arch Biochem Biophys 564:128-35. doi: 10.1016/j.abb.2014.09.017. Epub 2014 Oct 7. 2014
12CDC6, CDK2, CUL4B, MCM2
CUL4B promotes replication licensing by up-regulating the CDK2-CDC6 cascade.
Zou Y, Mi J, Wang W, Lu J, Zhao W, Liu Z, Hu H, Yang Y, Gao X, Jiang B, Shao C, Gong Y.
J Cell Biol 200(6):743-56. doi: 10.1083/jcb.201206065. Epub 2013 Mar 11. 2013
13CDC25B, CDK2, CETN2
CDC25B overexpression stabilises centrin 2 and promotes the formation of excess centriolar foci.
Boutros R, Mondesert O, Lorenzo C, Astuti P, McArthur G, Chircop M, Ducommun B, Gabrielli B.
PLoS One 8(7):e67822. doi: 10.1371/journal.pone.0067822. Print 2013. 2013
14CDK2, FOXP3
Foxp3 protein stability is regulated by cyclin-dependent kinase 2.
Morawski PA, Mehra P, Chen C, Bhatti T, Wells AD.
J Biol Chem 288(34):24494-502. doi: 10.1074/jbc.M113.467704. Epub 2013 Jul 12. 2013
15CCNA2, CDK1, CDK2
Cyclin-dependent kinase 1 (Cdk1) is essential for cell division and suppression of DNA re-replication but not for liver regeneration.
Diril MK, Ratnacaram CK, Padmakumar VC, Du T, Wasser M, Coppola V, Tessarollo L, Kaldis P.
Proc Natl Acad Sci U S A 109(10):3826-31. doi: 10.1073/pnas.1115201109. Epub 2012 Feb 21. 2012
16CDK2, CDK2AP1, CDK2AP2, IKBKE
Human cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is dimeric in its disulfide-reduced state, with natively disordered N-terminal region.
Ertekin A, Aramini JM, Rossi P, Leonard PG, Janjua H, Xiao R, Maglaqui M, Lee HW, Prestegard JH, Montelione GT.
J Biol Chem 287(20):16541-9. doi: 10.1074/jbc.M112.343863. Epub 2012 Mar 14. 2012
17CDK2
Cdk2 loss accelerates precursor differentiation and remyelination in the adult central nervous system.
Caillava C, Vandenbosch R, Jablonska B, Deboux C, Spigoni G, Gallo V, Malgrange B, Baron-Van Evercooren A.
J Cell Biol. 193(2):397-407. 2011
18CDK2
Mitotic progression becomes irreversible in prometaphase and collapses when Wee1 and Cdc25 are inhibited.
Potapova TA, Sivakumar S, Flynn JN, Li R, Gorbsky GJ.
Mol Biol Cell. 22(8):1191-206. 2011
19CDH1, CDK2, USP37
Deubiquitinase USP37 is activated by CDK2 to antagonize APC(CDH1) and promote S phase entry.
Huang X, Summers MK, Pham V, Lill JR, Liu J, Lee G, Kirkpatrick DS, Jackson PK, Fang G, Dixit VM.
Mol Cell 42(4):511-23. 2011
20CDK1, CDK2, CDK5, DNMT1
Phosphorylation of human DNMT1: implication of cyclin-dependent kinases.
Lavoie G, St-Pierre Y.
Biochem Biophys Res Commun 409(2):187-92. Epub 2011 May 1. 2011
21CDC6, CDK2, TREX1
Cdk2 is required for p53-independent G2/M checkpoint control.
Chung JH, Bunz F.
PLoS Genet 6(2):e1000863. 2010
22CDK1, CDK2, EZH2
Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2.
Chen S, Bohrer LR, Rai AN, Pan Y, Gan L, Zhou X, Bagchi A, Simon JA, Huang H.
Nat Cell Biol 2010 Oct 10. [Epub ahead of print]PMID: 20935635 2010
23CDK1, CDK2
Nuclear pore formation but not nuclear growth is governed by cyclin-dependent kinases (Cdks) during interphase.
Maeshima K, Iino H, Hihara S, Funakoshi T, Watanabe A, Nishimura M, Nakatomi R, Yahata K, Imamoto F, Hashikawa T, Yokota H, Imamoto N.
Nat Struct Mol Biol 17(9):1065-71. Epub 2010 Aug 15.PMID: 20711190 2010
24CDK2, CDK4, NPM2
Cdk2 and Cdk4 regulate the centrosome cycle and are critical mediators of centrosome amplification in p53-null cells.
Adon AM, Zeng X, Harrison MK, Sannem S, Kiyokawa H, Kaldis P, Saavedra HI.
Mol Cell Biol 30(3):694-710. doi: 10.1128/MCB.00253-09. Epub 2009 Nov 23. 2010
25CDK2
Expression and functional analysis of G1 to S regulatory components reveals an important role for CDK2 in cell cycle regulation in human embryonic stem cells.
Neganova I, Zhang X, Atkinson S, Lako M.
Oncogene 28(1):20-30. Epub 2008 Sep 22. 2009
26ANKRD17, CDK2
Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17.
Deng M, Li F, Ballif BA, Li S, Chen X, Guo L, Ye X.
J Biol Chem 284(12):7875-88. Epub 2009 Jan 16. 2009
27CCNE1, CDK2, HINFP, NPAT
The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles.
Xie R, Medina R, Zhang Y, Hussain S, Colby J, Ghule P, Sundararajan S, Keeler M, Liu LJ, van der Deen M, Mitra P, Lian JB, Rivera-Perez JA, Jones SN, Stein JL, van Wijnen AJ, Stein GS.
Proc Natl Acad Sci U S A 106(30):12359-64. Epub 2009 Jul 9. 2009
28CDK2, KAT2B
The transcriptional co-activator PCAF regulates cdk2 activity.
Mateo F, Vidal-Laliena M, Canela N, Zecchin A, Martínez-Balbás M, Agell N, Giacca M, Pujol MJ, Bachs O.
Nucleic Acids Res 37(21):7072-84. doi: 10.1093/nar/gkp777. Epub . 2009
29CCNE2, CDK2
Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.
Caldon CE, Sergio CM, Schütte J, Boersma MN, Sutherland RL, Carroll JS, Musgrove EA.
Mol Cell Biol 29(17):4623-39. doi: 10.1128/MCB.00269-09. Epub 2009 Jun 29. 2009
30CDK2
Evidence of key role of Cdk2 overexpression in pemphigus vulgaris.
Lanza A, Cirillo N, Rossiello R, Rienzo M, Cutillo L, Casamassimi A, de Nigris F, Schiano C, Rossiello L, Femiano F, Gombos F, Napoli C.
J Biol Chem 283(13):8736-45. Epub 2008 Jan 16. 2008
31CCNA1, CDK1, CDK2
Cyclin A/cdk2 coordinates centrosomal and nuclear mitotic events.
De Boer L, Oakes V, Beamish H, Giles N, Stevens F, Somodevilla-Torres M, Desouza C, Gabrielli B.
Oncogene 27(31):4261-8. Epub 2008 Mar 31. 2008
32CDK2
Autocatalytic phosphorylation of CDK2 at the activating Thr160.
Abbas T, Jha S, Sherman NE, Dutta A.
Cell Cycle 6(7):843-52. Epub 2007 Apr 13. 2007
33CDK2
CDK2 is dispensable for adult hippocampal neurogenesis.
Vandenbosch R, Borgs L, Beukelaers P, Foidart A, Nguyen L, Moonen G, Berthet C, Kaldis P, Gallo V, Belachew S, Malgrange B.
Cell Cycle 6(24):3065-9. Epub 2007 Sep 14.PMID: 18073538 2007
34ATRIP, CDK2
Cyclin-dependent kinase 2 dependent phosphorylation of ATRIP regulates the G2-M checkpoint response to DNA damage.
Myers JS, Zhao R, Xu X, Ham AJ, Cortez D.
Cancer Res 67(14):6685-90. 2007
35CDK2
CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage.
Huang H, Regan KM, Lou Z, Chen J, Tindall DJ.
Science 314(5797):294-7. 2006
36CDK2
Membrane depolarization stimulates the proliferation of SH-SY5Y human neuroblastoma cells by increasing retinoblastoma protein (RB) phosphorylation through the activation of cyclin-dependent kinase 2 (Cdk2).
Seo M, Kim Y, Lee YI, Kim SY, Ahn YM, Kang UG, Roh MS, Kim YS, Juhnn YS.
Neurosci Lett 404(1-2):87-92. Epub 2006 Jul 7. 2006
37CDK2
Phosphorylation of the linker histone H1 by CDK regulates its binding to HP1alpha.
Hale TK, Contreras A, Morrison AJ, Herrera RE.
Mol Cell 22(5):693-9. 2006
38CDK2
Phosphorylation of RIalpha by cyclin-dependent kinase CDK 2/cyclin E modulates the dissociation of the RIalpha-RFC40 complex.
Gupte RS, Traganos F, Darzynkiewicz Z, Lee MY.
Cell Cycle 5(6):653-60. Epub 2006 Mar 15. 2006
39CDK2, CDKN1A
Increased p21 expression and complex formation with cyclin E/CDK2 in retinoid-induced pre-B lymphoma cell apoptosis.
Bao GC, Wang JG, Jong A.
FEBS Lett 580(15):3687-93. Epub 2006 Jun 2. 2006
40CDK2
Human CDK2 inhibition modifies the dynamics of chromatin-bound minichromosome maintenance complex and replication protein A.
Zhu Y, Ishimi Y, Tanudji M, Lees E.
Cell Cycle 4(9):1254-63. Epub 2005 Sep 26. 2005
41CDK2
Cdk2-dependent Inhibition of p21 stability via a C-terminal cyclin-binding motif.
Zhu H, Nie L, Maki CG.
J Biol Chem 280(32):29282-8. Epub 2005 Jun 17. 2005
42CDK2
Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation.
Machida YJ, Teer JK, Dutta A.
J Biol Chem 280(30):27624-30. Epub 2005 Jun 7. 2005
43CDK2
CDK2 translational down-regulation during endothelial senescence.
Freedman DA, Folkman J.
Exp Cell Res 307(1):118-30. Epub 2005 Apr 21. 2005
44CDK2
Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R, Sato K, Wu W, Nishikawa T, Hiroi J, Ohtani-Kaneko R, Fukuda M, Ohta T.
Cancer Res 65(1):6-10. 2005
45CDK2
Cyclin-dependent kinase activity is required for progesterone receptor function: novel role for cyclin A/Cdk2 as a progesterone receptor coactivator.
Narayanan R, Adigun AA, Edwards DP, Weigel NL.
Mol Cell Biol 25(1):264-77. 2005
46CDK2, PURA
Functional interaction of Puralpha with the Cdk2 moiety of cyclin A/Cdk2.
Liu H, Barr SM, Chu C, Kohtz DS, Kinoshita Y, Johnson EM.
Biochem Biophys Res Commun 328(4):851-7. 2005
47CDK2, HSP90AA1
Proteomic analysis of human O6-methylguanine-DNA methyltransferase by affinity chromatography and tandem mass spectrometry.
Niture SK, Doneanu CE, Velu CS, Bailey NI, Srivenugopal KS.
Biochem Biophys Res Commun. 337(4):1176-84. 2005
48CDK2, UHRF2
NIRF induces G1 arrest and associates with Cdk2.
Li Y, Mori T, Hata H, Homma Y, Kochi H.
Biochem Biophys Res Commun 319(2):464-8. 2004
49CDK2
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF.
Du J, Widlund HR, Horstmann MA, Ramaswamy S, Ross K, Huber WE, Nishimura EK, Golub TR, Fisher DE.
Cancer Cell 6(6):565-76. 2004
50CCNA1, CDK2, INCA1, KLHDC9, PROCA1
Identification of interaction partners and substrates of the cyclin A1-CDK2 complex.
Diederichs S, Bäumer N, Ji P, Metzelder SK, Idos GE, Cauvet T, Wang W, Möller M, Pierschalski S, Gromoll J, Schrader MG, Koeffler HP, Berdel WE, Serve H, Müller-Tidow C.
J Biol Chem 279(32):33727-41. Epub 2004 May 24. 2004
51CDK2
Cyclin-dependent kinases regulate the antiproliferative function of Smads.
Matsuura I, Denissova NG, Wang G, He D, Long J, Liu F.
Nature. 430(6996):226-31. 2004
52CDK2
p42, a novel cyclin-dependent kinase-activating kinase in mammalian cells.
Liu Y, Wu C, Galaktionov K.
J Biol Chem. 279(6):4507-14. 2004
53IRF1, CDK2
The tumor suppressor interferon regulatory factor 1 interferes with SP1 activation to repress the human CDK2 promoter.
Xie RL, Gupta S, Miele A, Shiffman D, Stein JL, Stein GS, van Wijnen AJ.
J Biol Chem 278(29):26589-96. Epub 2003 May 5. 2003
54CDK2
Cyclin-dependent kinase 2 is essential for meiosis but not for mitotic cell division in mice.
Ortega S, Prieto I, Odajima J, Martín A, Dubus P, Sotillo R, Barbero JL, Malumbres M, Barbacid M.
Nat Genet. 35(1):25-31 2003
55CDK2, SPDYA
Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.
Porter LA, Dellinger RW, Tynan JA, Barnes EA, Kong M, Lenormand JL, Donoghue DJ.
J Cell Biol 157(3):357-66. Epub 2002 Apr 29. 2002
56CDK2
Characterization and expression of mammalian cyclin b3, a prepachytene meiotic cyclin.
Nguyen TB, Manova K, Capodieci P, Lindon C, Bottega S, Wang XY, Refik-Rogers J, Pines J, Wolgemuth DJ, Koff A.
J Biol Chem. 277(44):41960-9. 2002
57CDK2
Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop.
Garrett S, Barton WA, Knights R, Jin P, Morgan DO, Fisher RP.
Mol Cell Biol. 21(1):88-99. 2001
58CDK2
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
Song H, Hanlon N, Brown NR, Noble ME, Johnson LN, Barford D.
Mol Cell. 7(3):615-26. 2001
59CDK2
HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C, Nelson DM, Ye X, Baker K, DeCaprio JA, Seeholzer S, Lipinski M, Adams PD.
Mol Cell Biol. 21(5):1854-65. 2001
60CDK2
C/EBPalpha arrests cell proliferation through direct inhibition of Cdk2 and Cdk4.
Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA.
Mol Cell. 8(4):817-28. 2001
61CDK2
Cyclin A1 directly interacts with B-myb and cyclin A1/cdk2 phosphorylate B-myb at functionally important serine and threonine residues: tissue-specific regulation of B-myb function.
Müller-Tidow C, Wang W, Idos GE, Diederichs S, Yang R, Readhead C, Berdel WE, Serve H, Saville M, Watson R, Koeffler HP.
Blood. 97(7):2091-7. 2001
62CDK2, CDKN3
Phosphoprotein-protein interactions revealed by the crystal structure of kinase-associated phosphatase in complex with phosphoCDK2.
Song H, Hanlon N, Brown NR, Noble ME, Johnson LN, Barford D.
Mol Cell 7(3):615-26. 2001
63CCNE1, CDK2, NPM1
Nucleophosmin/B23 is a target of CDK2/cyclin E in centrosome duplication.
Okuda M, Horn HF, Tarapore P, Tokuyama Y, Smulian AG, Chan PK, Knudsen ES, Hofmann IA, Snyder JD, Bove KE, Fukasawa K.
Cell 103(1):127-40. 2000
64CDK2
p12(DOC-1) is a novel cyclin-dependent kinase 2-associated protein.
Shintani S, Ohyama H, Zhang X, McBride J, Matsuo K, Tsuji T, Hu MG, Hu G, Kohno Y, Lerman M, Todd R, Wong DT.
Mol Cell Biol. 20(17):6300-7. 2000
65CDK2
A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA-interacting proteins for phosphorylation.
Koundrioukoff S, Jónsson ZO, Hasan S, de Jong RN, van der Vliet PC, Hottiger MO, Hübscher U.
J Biol Chem. 275(30):22882-7. 2000
66CDK2
PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes.
Kashiwagi M, Ohba M, Watanabe H, Ishino K, Kasahara K, Sanai Y, Taya Y, Kuroki T.
Oncogene. 19(54):6334-41. 2000
67CDK2
Stress-induced activation of protein kinase CK2 by direct interaction with p38 mitogen-activated protein kinase.
Sayed M, Kim SO, Salh BS, Issinger OG, Pelech SL.
J Biol Chem 275(22):16569-73 2000
68CDK2
TOK-1, a novel p21Cip1-binding protein that cooperatively enhances p21-dependent inhibitory activity toward CDK2 kinase.
Ono T, Kitaura H, Ugai H, Murata T, Yokoyama KK, Iguchi-Ariga SM, Ariga H.
J Biol Chem. 275(40):31145-54. 2000
69CDK2, CCNE1
Deregulated cyclin E induces chromosome instability.
Spruck CH, et al.
Nature 401(6750):297-300 1999
70CCNA2, CDK2, SKP2
Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.
Yam CH, Ng RW, Siu WY, Lau AW, Poon RY.
Mol Cell Biol 19(1):635-45. 1999
71CDK2
Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers.
Gudas JM, Payton M, Thukral S, Chen E, Bass M, Robinson MO, Coats S.
Mol Cell Biol. 19(1):612-22. 1999
72CDK2
Phosphorylation of mammalian CDC6 by cyclin A/CDK2 regulates its subcellular localization.
Petersen BO, Lukas J, Sřrensen CS, Bartek J, Helin K.
EMBO J. 18(2):396-410. 1999
73CDK2
Regulation of cyclin A-Cdk2 by SCF component Skp1 and F-box protein Skp2.
Yam CH, Ng RW, Siu WY, Lau AW, Poon RY.
Mol Cell Biol. 19(1):635-45. 1999
74CDK2
Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F.
Ohtani K, Tsujimoto A, Ikeda M, Nakamura M.
Oncogene 17 : 1777-1785. 1998
75BAX, BCL2, CDK2
A link between cell cycle and cell death : Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis.
Gil-Gomez G, Berns A, Brady HJ.
EMBO J 17 : 7209-7218. 1998
76CDK2
Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK).
Mandal M, Bandyopadhyay D, Goepfert TM, Kumar R.
Oncogene. 16(2):217-25. 1998
77CDK2
Characterization of the p125 subunit of human DNA polymerase delta and its deletion mutants. Interaction with cyclin-dependent kinase-cyclins.
Wu SM, Zhang P, Zeng XR, Zhang SJ, Mo J, Li BQ, Lee MY.
J Biol Chem. 273(16):9561-9. 1998
78CDK2
Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase.
Chen E, Li CC.
Biochem Biophys Res Commun. 249(3):728-34. 1998
79CDK2
BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H, Shao N, Ding QM, Cui J, Reddy ES, Rao VN.
Oncogene. 15(2):143-57. 1997
80CDK2
Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes.
Lacy S, Whyte P.
Oncogene. 14(20):2395-406. 1997
81CDK2
Characterization of the human cyclin-dependent kinase 2 gene. Promoter Analysis and gene structure.
Shiffman D, et al.
J Biol Chem 271 : 12199-12204. 1996
82CDK2
Interaction of cyclin-dependent kinase 2 and the Lyn tyrosine kinase in cells treated with 1-beta-D-arabinofuranosylcytosine.
Yuan ZM, Huang Y, Kraeft SK, Chen LB, Kharbanda S, Kufe D.
Oncogene. 13(5):939-46. 1996
83CDK2
Crystal structure and mutational analysis of the human CDK2 kinase complex with cell cycle-regulatory protein CksHs1.
Bourne Y, Watson MH, Hickey MJ, Holmes W, Rocque W, Reed SI, Tainer JA.
Cell. 84(6):863-74. 1996
84CDK2
Roles of active site residues and the NH2-terminal domain in the catalysis and substrate binding of human Cdc25.
Xu X, Burke SP.
J Biol Chem. 271(9):5118-24. 1996
85CDK2
Poon RY, Jiang W, Toyoshima H, Hunter T.
J Biol Chem. 271(22):13283-91. 1996
86CDK2, CDK4, CDK5
Chromosomal mapping of human CDK2,CDK4, and CDK5 cell cycle kinase genes.
Demetrick DJ, et al.
Cytogenet Cell Genet 66 : 72-74. 1994
87CDK2, E2F1
Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
Xu M, Sheppard KA, Peng CY, Yee AS, Piwnica-Worms H.
Mol Cell Biol. 14(12):8420-31. 1994
88CDK1, CDK2
KAP: a dual specificity phosphatase that interacts with cyclin-dependent kinases.
Hannon GJ, Casso D, Beach D.
Proc Natl Acad Sci U S A. 91(5):1731-5. 1994
89CDK2
Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2.
Gyuris J, Golemis E, Chertkov H, Brent R.
Cell. 75(4):791-803. 1993
90CDK2
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.
Koff A, Giordano A, Desai D, Yamashita K, Harper JW, Elledge S, Nishimoto T, Morgan DO, Franza BR, Roberts JM.
Science. 257(5077):1689-94. 1992